According to Collegium Pharmaceutical
's latest financial reports the company has โน13.90 Billion in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2024-12-31 | โน13.96 B | -45.99% |
2023-12-31 | โน25.85 B | 79.87% |
2022-12-31 | โน14.37 B | 3.58% |
2021-12-31 | โน13.87 B | 8.97% |
2020-12-31 | โน12.73 B | 5.03% |
2019-12-31 | โน12.12 B | 18.25% |
2018-12-31 | โน10.25 B | 35.28% |
2017-12-31 | โน7.57 B | -27.21% |
2016-12-31 | โน10.41 B | 63.73% |
2015-12-31 | โน6.35 B | 6040.95% |
2014-12-31 | โน0.10 B | -77.8% |
2013-12-31 | โน0.46 B |